Tirzepatide Hydrochloride is a first-in-class glucose-dependent insulin-stimulating peptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist for the study of diabetes mellitus.
Molecular Weight:
4849.91
Purity:
99.40%
Formula:
C225H348N48O68.HCl
Target:
GLP Receptor
* VAT and and shipping costs not included. Errors and price changes excepted
